The European Research council just awarded an ERC Advanced Grant to Bernhard Küster and his team at the Chair for Proteomics and Bioanalytics. The proposal titled "Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies" will investigate the protein activity in diseased tissue with the goal to derive at a better understanding of the underlying cancer and suggest targeted therapies for the individual patient with the overall aim to more tightly connect quantitative proteomics and medical science.